Tracon Pharmaceuticals, Inc. - FORM S-1 - EX-23.1 - December 29, 2014

Attached files

file filename
S-1 - S-1 - Tracon Pharmaceuticals, Inc.a2221572zs-1.htm
EX-3.1 - EX-3.1 - Tracon Pharmaceuticals, Inc.a2221572zex-3_1.htm
EX-10.1 - EX-10.1 - Tracon Pharmaceuticals, Inc.a2221572zex-10_1.htm
EX-3.3 - EX-3.3 - Tracon Pharmaceuticals, Inc.a2221572zex-3_3.htm
EX-4.2 - EX-4.2 - Tracon Pharmaceuticals, Inc.a2221572zex-4_2.htm
EX-10.2 - EX-10.2 - Tracon Pharmaceuticals, Inc.a2221572zex-10_2.htm
EX-10.13 - EX-10.13 - Tracon Pharmaceuticals, Inc.a2221572zex-10_13.htm
EX-10.9 - EX-10.9 - Tracon Pharmaceuticals, Inc.a2221572zex-10_9.htm
EX-10.19 - EX-10.19 - Tracon Pharmaceuticals, Inc.a2221572zex-10_19.htm
EX-10.18 - EX-10.18 - Tracon Pharmaceuticals, Inc.a2221572zex-10_18.htm
EX-10.10 - EX-10.10 - Tracon Pharmaceuticals, Inc.a2221572zex-10_10.htm
EX-10.5 - EX-10.5 - Tracon Pharmaceuticals, Inc.a2221572zex-10_5.htm
EX-10.21 - EX-10.21 - Tracon Pharmaceuticals, Inc.a2221572zex-10_21.htm
EX-10.15 - EX-10.15 - Tracon Pharmaceuticals, Inc.a2221572zex-10_15.htm
EX-10.7 - EX-10.7 - Tracon Pharmaceuticals, Inc.a2221572zex-10_7.htm
EX-10.20 - EX-10.20 - Tracon Pharmaceuticals, Inc.a2221572zex-10_20.htm
EX-10.12 - EX-10.12 - Tracon Pharmaceuticals, Inc.a2221572zex-10_12.htm
EX-10.11 - EX-10.11 - Tracon Pharmaceuticals, Inc.a2221572zex-10_11.htm
EX-10.6 - EX-10.6 - Tracon Pharmaceuticals, Inc.a2221572zex-10_6.htm
EX-10.8 - EX-10.8 - Tracon Pharmaceuticals, Inc.a2221572zex-10_8.htm
EX-10.17 - EX-10.17 - Tracon Pharmaceuticals, Inc.a2221572zex-10_17.htm
EX-10.14 - EX-10.14 - Tracon Pharmaceuticals, Inc.a2221572zex-10_14.htm
EX-10.16 - EX-10.16 - Tracon Pharmaceuticals, Inc.a2221572zex-10_16.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

          We consent to the reference to our firm under the caption "Experts" and to the use of our report dated August 8, 2014, in the Registration Statement (Form S-1) and related Prospectus of TRACON Pharmaceuticals, Inc. for the registration of shares of its common stock.

                        /s/ Ernst & Young LLP

San Diego, California
December 29, 2014



QuickLinks

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Tracon Pharmaceuticals, Inc. Reports